Tri-vylibra Kit
Product Images NDC 50102-233

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tri-vylibra (NDC 50102-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Norgestimate Fig1)

An instructional illustration showing how to use day-of-the-week labels on a Tri-VyLibra kit blister card. It depicts a hand peeling a day label to place above the medication slots, which are color-coded in white, light blue, dark blue, and green for different weeks and levels of tablets containing Norgestimate and Ethinyl Estradiol.*

FDA Label Image

Figure-2 (Norgestimate Fig2)

Tri-VyLibra kit contains tablets of Norgestimate and Ethinyl Estradiol arranged in a weekly dosing chart with color-coded rows: white, light blue, dark blue, and green. Each colored row corresponds to different dosages progressing from 0.180 mg/0.035 mg through 0.250 mg/0.035 mg. The kit is labeled by Afaxys Pharma, LLC and organized by days of the week from Sunday to Saturday to guide daily tablet use.*

FDA Label Image

Figure-3 (Norgestimate Fig3)

A forest plot comparing the effect estimates of contraceptive use studies, with two groups: Ever COC vs. Never COC Use and Current COC Use vs. Never-Use. The plot includes study names, effect estimates with confidence intervals represented as dots and horizontal lines, and corresponding OR, RR, and HR values on the right side. The x-axis is labeled Effect Estimate with values ranging from -1.50 to 2.00.*

FDA Label Image

Figure-4 (Norgestimate Fig4)

A vertical effectiveness chart ranking birth control methods by pregnancy rates per 100 women per year. Methods with fewer pregnancies at the top include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones. Condoms and diaphragm are in the middle, while no sex during fertile days, spermicide, and withdrawal show higher pregnancy rates. No birth control is associated with the highest pregnancy rate at the bottom.*

FDA Label Image

Figure-5 (Norgestimate Fig5)

An instructional diagram illustrating the Tri-VyLibra oral contraceptive kit by Afaxys Pharma, LLC. It shows a hand peeling and placing a day label (Mon-Sun) onto a tablet card containing four rows of tablets. The rows are color-coded: white for Week 1, light blue for Week 2, dark blue for Week 3, and green for Week 4, with corresponding dosage strengths labeled beside them. The diagram guides users on starting the medication and organizing intake by days of the week.*

FDA Label Image

Package Label-principal Display Panel- Carton Label (Norgestimate Fig6)

Tri-VyLibra oral contraceptive kit containing active and inactive tablets across four weeks, color-coded by week: white for week 1, light blue for week 2, dark blue for week 3, and green for week 4. Tablets are arranged by day of the week, with each row labeled for its respective week and dosage information for active pills provided in the third week row.*

FDA Label Image

Norgestimate Fig7

Tri-VyLibra kit packaging label for tablets containing Norgestimate and Ethinyl Estradiol in strengths 0.180 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.250 mg/0.035 mg. The label indicates a blister card of 28 tablets, with different colored tablets for varying doses. Manufactured for Afaxys Pharma, LLC, Charleston, SC, and by Aurobindo Pharma Limited, India. Includes dosage and usage instructions.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagrams of the active ingredients Norgestimate and Ethinyl Estradiol for the prescription drug Tri-VyLibra by Afaxys Pharma, LLC. The image shows labeled molecular structures for both steroid hormones without additional chemical details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.